SELLAS Life Sciences (SLS) Change in Cash (2010 - 2026)

SELLAS Life Sciences (SLS) reported Change in Cash of $35.3 million for Q1 2026, up 143.29% year-over-year from $14.5 million in Q1 2025, and up 28.5% on a QoQ basis from $27.5 million in Q4 2025.

SELLAS Life Sciences (SLS) has 17 years of Change in Cash data on file, last reported at $35.3 million in Q1 2026.

  • Quarterly Change in Cash rose 143.29% year-over-year to $35.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $78.7 million (up 688.42% YoY) and the FY2025 annual result came in at $57.9 million, up 409.92% from the prior year.
  • Change in Cash grew to $35.3 million in Q1 2026 per SLS's latest filing, from $27.5 million in the prior quarter.
  • Across five years, Change in Cash topped out at $35.3 million in Q1 2026 and bottomed at -$10.1 million in Q2 2023.
  • The 5-year median for Change in Cash is -$1.4 million (2023), against an average of $5.0 million.
  • The widest annual swing landed in 2022, when Change in Cash soared 575.96%; it then slumped 396.53% in 2024.
  • Tracing SLS's Change in Cash over 5 years: stood at -$4.2 million in 2022, then jumped by 65.92% to -$1.4 million in 2023, then plunged by 396.53% to -$7.1 million in 2024, then soared by 484.51% to $27.5 million in 2025, then advanced by 28.5% to $35.3 million in 2026.
  • Per Business Quant, the three latest SLS Change in Cash figures stand at $35.3 million (Q1 2026), $27.5 million (Q4 2025), and $19.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 2.44 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 623.00 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -2.44 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 417.10 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -153.10 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 53.61 Mn
10 SELLAS Life Sciences 1.61 Bn 1.61 Bn - 35.30 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 35.30 Mn
Dec 31, 2025 27.47 Mn
Sep 30, 2025 19.02 Mn
Jun 30, 2025 -3.10 Mn
Mar 31, 2025 14.51 Mn
Dec 31, 2024 -7.15 Mn
Sep 30, 2024 11.88 Mn
Jun 30, 2024 -9.27 Mn
Mar 31, 2024 15.89 Mn
Dec 31, 2023 -1.44 Mn
Sep 30, 2023 -9.84 Mn
Jun 30, 2023 -10.10 Mn
Mar 31, 2023 6.78 Mn
Dec 31, 2022 -4.22 Mn
Sep 30, 2022 -5.64 Mn
Jun 30, 2022 12.74 Mn
Mar 31, 2022 -7.10 Mn
Dec 31, 2021 -4.93 Mn
Sep 30, 2021 -3.64 Mn
Jun 30, 2021 1.88 Mn
Mar 31, 2021 -7.27 Mn
Dec 31, 2020 27.10 Mn
Sep 30, 2020 4.86 Mn
Jun 30, 2020 -3.41 Mn
Mar 31, 2020 -531,000.00
Dec 31, 2019 -1.86 Mn
Sep 30, 2019 -3.63 Mn
Jun 30, 2019 10.18 Mn
Mar 31, 2019 -2.76 Mn
Dec 31, 2018 -4.63 Mn
Sep 30, 2018 87,000.00
Jun 30, 2018 -2.09 Mn
Mar 31, 2018 -664,000.00
Dec 31, 2017 10.30 Mn
Sep 30, 2017 -2.40 Mn
Jun 30, 2017 2.61 Mn
Mar 31, 2017 -3.80 Mn
Dec 31, 2016 9.78 Mn
Sep 30, 2016 4.92 Mn
Jun 30, 2016 -15.12 Mn
Mar 31, 2016 4.98 Mn
Dec 31, 2015 -5.08 Mn
Sep 30, 2015 -10.47 Mn
Jun 30, 2015 -7.58 Mn
Mar 31, 2015 29.21 Mn
Dec 31, 2014 -997,000.00
Sep 30, 2014 -14.52 Mn
Jun 30, 2014 -13.27 Mn
Mar 31, 2014 4.64 Mn
Dec 31, 2013 -3.61 Mn
Sep 30, 2013 30.48 Mn
Jun 30, 2013 3.44 Mn
Mar 31, 2013 -15.33 Mn
Dec 31, 2012 17.38 Mn
Sep 30, 2012 -3.81 Mn
Jun 30, 2012 10.53 Mn
Mar 31, 2012 -2.73 Mn
Dec 31, 2011 -4.26 Mn
Sep 30, 2011 -2.24 Mn
Jun 30, 2011 6.82 Mn
Mar 31, 2011 4.22 Mn
Dec 31, 2010 4.06 Mn
Sep 30, 2010 -2.26 Mn